Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Emilio J Sanz Alvarez

Médico Adjunto. Catedrático vinculado (Farmacología Clínica)

Hospital Universitario de Canarias

Spain

Research Interests

Explore related searches

Professors in Spain

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (12)

Joseph Friedman

Program Director

Brown University

UNITED STATES

View details

Robert A. Bittner

University Hospital Frankfurt

GERMANY

View details

Celso Arango

Distinguished Researcher

Universidad Autónoma de Madrid

SPAIN

View details

Carmen Moreno

Head Section at Child and Adolescent Psychiatry Department

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Carlos De Las Cuevas

Researcher

Universidad de la Laguna

SPAIN

View details

Robert Cotes

Professor

Emory University

UNITED STATES

View details

Heidi Taipale

University of Eastern Finland

FINLAND

View details

Georgios Schoretsanitis

Research Scientist

University of Zurich

SWITZERLAND

View details

Paraskevi Papaioannidou

Professor

Aristotle University of Thessaloniki

GREECE

View details

John Davis

Professor

University of Illinois Chicago (UIC)

UNITED STATES

View details

Jose de Leon

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Leslie Citrome

New York Medical College

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emilio J Sanz Alvarez

Research Interests

Explore related searches

Articles (20)

Reply to “Beyond Hypersalivation: Protecting Older Clozapine Users through Better Recognition of Swallowing Vulnerability”

Informing Your Future Clozapine Patients of the Mortality Risk: Fear of Agranulocytosis vs. Pharmacovigilance Fatal Outcomes

A Systematic Review and a VigiBase Study of Accidental Clozapine Intoxications in Children and Adolescents

VigiBase suggests that the number of deaths by suicide in adolescents with schizophrenia as a result of not taking clozapine may be much higher than the number of deaths from agranulocytosis after taking clozapine

A study in VigiBase of clozapine fatal outcomes in 7874 middle-aged versus 4380 young adults

A Comparative Analysis of Fatal Outcomes in 5,370 Geriatric Versus 12,254 Nongeriatric Adult Patients: A Clozapine Study in VigiBase

Clozapine and Suicide in VigiBase

Deprescription of proton pump inhibitors in the primary care setting in the Canary Islands. A randomized massive educational intervention

The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey

Barriers and solutions for the European prescribing exam: a qualitative world café study

The Feasibility and Quality of the European Prescribing Exam: An International Multicenter Pilot Study Among 3109 Medical Students From 16 Medical Schools

Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data

Clozapine-treated patients and myocardial infarction in adults: a pharmacovigilance study in VigiBase interpreted in the context of the literature

Clozapine pharmacovigilance in Croatia: Underreporting of specific adverse drug reactions and excellent reporting of suicide attempts

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II

The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force.

Fatal Outcomes in Use of Clozapine

Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

Collaborators (12)

Joseph Friedman

Robert A. Bittner

Celso Arango

Carmen Moreno

Carlos De Las Cuevas

Robert Cotes

Heidi Taipale

Georgios Schoretsanitis

Paraskevi Papaioannidou

John Davis

Jose de Leon

Leslie Citrome

Make your next move.